Skip to main content

Clinical Watch: December 2018

Published Date

In this issue of Clinical Watch, we describe expanded uses of Hemlibra® and suggest criteria for the use of Dupixent® to treat severe asthma.

Download PDF

In this issue of Clinical Watch, we describe expanded uses of Hemlibra® and suggest criteria for the use of Dupixent® to treat severe asthma. We also review a study evaluating factors associated with non-adherence to essential chronic medications. Lastly, we review the prevalence of opioid polypharmacy in two Medicaid pharmacy programs.

For more information about our solutions, please visit conduent.com/pharmacysolutions.

Print